TEPRASIRAN SODIUM
UNII ME0IRL7KDY

Substance Identification & Data

This profile provides standardized clinical and technical data for Teprasiran Sodium, uniquely identified by the FDA Unique Ingredient Identifier (UNII) ME0IRL7KDY.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2169310-72-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
ME0IRL7KDY
CAS Registry Number
2169310-72-7
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
TEPRASIRAN SODIUM
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C174706
National Cancer Institute reference terminology for clinical and research data.
USAN ID
FG-143
Identifier assigned by the United States Adopted Names Council.
Substance Type
nucleicAcid
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Teprasiran Sodium. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TEPRASIRAN SODIUM

Common Names & Synonyms

TEPRASIRAN SODIUM [USAN]

Systematic Nomenclature

GUANYLYL-(3'->5')-2'-O-METHYLADENYLYL-(3'->5')-GUANYLYL- (3'->5')-2'-O-METHYLADENYLYL-(3'->5')-ADENYLYL-(3'->5')-2'-OMETHYLURIDYLYL-(3'->5')-ADENYLYL-(3'->5')-2'-O-METHYLURIDYLYL- (3'->5')-URIDYLYL-(3'->5')-2'-O-METHYLURIDYLYL-(3'->5')- CYTIDYLYL-(3'->5')-2'-O-METHYLADENYLYL-(3'->5')-CYTIDYLYL- (3'->5')-2'-O-METHYLCYTIDYLYL-(3'->5')-CYTIDYLYL-(3'->5')-2'-OMETHYLURIDYLYL-(3'->5')-URIDYLYL-(3'->5')-2'-O-METHYLCYTIDYLYL- (3'->5')-ADENOSINE, SODIUM SALT, DUPLEX WITH 2'-O-METHYLURIDYLYL-(3'->5')- GUANYLYL-(3'->5')-2'-O-METHYLADENYLYL-(3'->5')-ADENYLYL- (3'->5')-2'-O-METHYLGUANYLYL-(3'->5')-GUANYLYL-(3'->5')-2'-OMETHYLGUANYLYL-(3'->5')-URIDYLYL-(3'->5')-2'-OMETHYLGUANYLYL-(3'->5')-ADENYLYL-(3'->5')-2'-OMETHYLADENYLYL-(3'->5')-ADENYLYL-(3'->5')-2'-OMETHYLURIDYLYL-(3'->5')-ADENYLYL-(3'->5')-2'-O-METHYLURIDYLYL- (3'->5')-URIDYLYL-(3'->5')-2'-O-METHYLCYTIDYLYL-(3'->5')- URIDYLYL-(3'->5')-2'-O-METHYLCYTIDINE, SODIUM SALT
RNA, (G-AM-G-AM-A-UM-A-UM-U-UM-C-AM-C-CM-C-UM-U-CM-A), SODIUM SALT, COMPLEX WITH RNA (UM-G-AM-A-GM-G-GM-U-GM-A-AM-A-UM-A-UM-U-CM-U-CM) SODIUM SALT (1:18:1:18)

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus